Wednesday, July 8, 2026

pharma · Alzheimer Disease · Amyotrophic Lateral Sclerosis · AMLX

Amylyx Pharmaceuticals EMEA

Amylyx Pharmaceuticals EMEA trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.

Cambridge, USA HQ
167 Employees
Public company Type
AMLX · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Employees
167
Programs
7
Drugs
2
Patents
9
Intelligence · Clinical Trials

Amylyx Pharmaceuticals EMEA clinical trials

Registry index of 11 ClinicalTrials.gov studies linked to Amylyx Pharmaceuticals EMEA programs — each row shows trial ID, program name, phase, status, and indication.

Amylyx Pharmaceuticals EMEA trial registry — 11 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

7 updates

Latest clinical program signals indexed for Amylyx Pharmaceuticals EMEA.

  1. AMX0114 — Phase 1

    Clinical update
  2. AMX0035 — Phase 2

    Clinical update
  3. AMX0035 — Phase 2

    Clinical update
  4. AMX0035 — Phase 3

    Clinical update
  5. AMX0035 — Phase 3

    Clinical update
  6. Avexitide — Phase 3

    Clinical update
  7. AMX0035 — Phase 2

    Clinical update

Trial registry

11 studies